{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:01:20Z","timestamp":1791846080649,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00281553"],"award-info":[{"award-number":["RS-2023-00281553"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020M3A9D8038192"],"award-info":[{"award-number":["2020M3A9D8038192"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00553501"],"award-info":[{"award-number":["RS-2025-00553501"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-16063013"],"award-info":[{"award-number":["RS-2025-16063013"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2025-25454860"],"award-info":[{"award-number":["RS-2025-25454860"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Senescent cells contribute to degenerative processes in multiple tissues, including the retina. In the retinal pigment epithelium (RPE), their accumulation is closely associated with retinal aging and disease progression. Eliminating senescent RPE cells has shown therapeutic potential, but conventional senolytics often lack the specificity required to spare non-senescent cells, raising safety concerns. To overcome this, we performed integrated transcriptomic analyses of male mouse-derived RPE cells under natural aging and chemically induced senescence conditions. These analyses identified Bst2 as a membrane-localized marker selectively upregulated in senescent RPE cells, with minimal expression in young controls. Based on this discovery, we developed a modular, antibody-pluggable drug delivery platform\u2013B-Z-PON\u2013comprising mesoporous silica nanoparticles functionalized with a recombinant Fc-binding domain and conjugated with anti-Bst2 antibodies. This nanocarrier selectively accumulates in Bst2-expressing senescent RPE cells, enabling targeted drug delivery and sparing healthy retinal cells. In vivo administration of ABT-263-loaded B-Z-PON in aged and senescence-induced retinal degeneration models resulted in the selective ablation of senescent cells, restoration of RPE function, and improved visual outcomes. Together, our study integrates senescence-specific marker discovery with precision nanomedicine, establishing a versatile platform for targeted senotherapy. These findings offer a promising therapeutic approach for retinal aging disorders, such as age-related macular degeneration.<\/jats:p>","DOI":"10.1038\/s41467-026-70797-2","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:33:24Z","timestamp":1773837204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bst2-targeted senotherapy restores visual function by eliminating senescent retinal cells"],"prefix":"10.1038","volume":"17","author":[{"given":"Jun Yong","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Byoung","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minseo","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyuri","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6219-8989","authenticated-orcid":false,"given":"Yujeong","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeongseok","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangpil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Won","family":"Ok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dohyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaekyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9015-6046","authenticated-orcid":false,"given":"Semin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5884-5685","authenticated-orcid":false,"given":"Jiwon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1312-6406","authenticated-orcid":false,"given":"Hyewon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0252-0985","authenticated-orcid":false,"given":"Ja-Hyoung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"70797_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","volume":"7","author":"J Guo","year":"2022","unstructured":"Guo, J. et al. Aging and aging-related diseases: From molecular mechanisms to interventions and treatments. Signal Transduct. Target. Ther. 7, 391 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"70797_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","volume":"22","author":"R Di Micco","year":"2021","unstructured":"Di Micco, R., Krizhanovsky, V., Baker, D. & d\u2019Adda di Fagagna, F. Cellular senescence in ageing: From mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell Biol. 22, 75\u201395 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"70797_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrm3823","volume":"15","author":"D Mu\u00f1oz-Esp\u00edn","year":"2014","unstructured":"Mu\u00f1oz-Esp\u00edn, D. & Serrano, M. Cellular senescence: From physiology to pathology. Nat. Rev. Mol. Cell Biol. 15, 482\u2013496 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"70797_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: An expanding universe. Cell 186, 243\u2013278 (2023).","journal-title":"Cell"},{"key":"70797_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41573-024-01074-4","volume":"24","author":"D McHugh","year":"2025","unstructured":"McHugh, D., Dur\u00e1n, I. & Gil, J. Senescence as a therapeutic target in cancer and age-related diseases. Nat. Rev. Drug Discov. 24, 57\u201371 (2025).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70797_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","volume":"18","author":"W Huang","year":"2022","unstructured":"Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L. & Lerman, L. O. Cellular senescence: the good, the bad and the unknown. Nat. Rev. Nephrol. 18, 611\u2013627 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"70797_CR7","doi-asserted-by":"crossref","unstructured":"Zhang, L. et al. Cellular senescence: A key therapeutic target in aging and diseases. J. Clin. Investig. 132, e158450 (2022).","DOI":"10.1172\/JCI158450"},{"key":"70797_CR8","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/s41591-022-01923-y","volume":"28","author":"S Chaib","year":"2022","unstructured":"Chaib, S., Tchkonia, T. & Kirkland, J. L. Cellular senescence and senolytics: The path to the clinic. Nat. Med. 28, 1556\u20131568 (2022).","journal-title":"Nat. Med."},{"key":"70797_CR9","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4000","volume":"21","author":"BG Childs","year":"2015","unstructured":"Childs, B. G., Durik, M., Baker, D. J. & van Deursen, J. M. Cellular senescence in aging and age-related disease: From mechanisms to therapy. Nat. Med 21, 1424\u20131435 (2015).","journal-title":"Nat. Med"},{"key":"70797_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/physrev.00021.2004","volume":"85","author":"O Strauss","year":"2005","unstructured":"Strauss, O. The retinal pigment epithelium in visual function. Physiol. Rev. 85, 845\u2013881 (2005).","journal-title":"Physiol. Rev."},{"key":"70797_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1177\/1535370215587530","volume":"240","author":"J Stern","year":"2015","unstructured":"Stern, J. & Temple, S. Retinal pigment epithelial cell proliferation. Exp. Biol. Med (Maywood) 240, 1079\u20131086 (2015).","journal-title":"Exp. Biol. Med (Maywood)"},{"key":"70797_CR12","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(08)61759-6","volume":"372","author":"HR Coleman","year":"2008","unstructured":"Coleman, H. R., Chan, C.-C., Ferris, F. L. & Chew, E. Y. III Age-related macular degeneration.  Lancet 372, 1835\u20131845 (2008).","journal-title":"Lancet"},{"key":"70797_CR13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00018-019-03420-x","volume":"77","author":"J Blasiak","year":"2020","unstructured":"Blasiak, J. Senescence in the pathogenesis of age-related macular degeneration. Cell. Mol. life Sci. 77, 789\u2013805 (2020).","journal-title":"Cell. Mol. life Sci."},{"key":"70797_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.mehy.2012.01.018","volume":"78","author":"MR Kozlowski","year":"2012","unstructured":"Kozlowski, M. R. RPE cell senescence: A key contributor to age-related macular degeneration. Med. Hypotheses 78, 505\u2013510 (2012).","journal-title":"Med. Hypotheses"},{"key":"70797_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/ceo.13834","volume":"48","author":"S Somasundaran","year":"2020","unstructured":"Somasundaran, S., Constable, I. J., Mellough, C. B. & Carvalho, L. S. Retinal pigment epithelium and age-related macular degeneration: A review of major disease mechanisms. Clin. Exp. Ophthalmol. 48, 1043\u20131056 (2020).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"70797_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","volume":"60","author":"S Datta","year":"2017","unstructured":"Datta, S., Cano, M., Ebrahimi, K., Wang, L. & Handa, J. T. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog. Retin Eye Res. 60, 201\u2013218 (2017).","journal-title":"Prog. Retin Eye Res."},{"key":"70797_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02088-0","volume":"18","author":"KS Lee","year":"2021","unstructured":"Lee, K. S., Lin, S., Copland, D. A., Dick, A. D. & Liu, J. Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration. J. Neuroinflamm. 18, 32 (2021).","journal-title":"J. Neuroinflamm."},{"key":"70797_CR18","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1016\/S2666-7568(21)00300-7","volume":"3","author":"M Raffaele","year":"2022","unstructured":"Raffaele, M. & Vinciguerra, M. The costs and benefits of senotherapeutics for human health.  lancet Healthy Longev. 3, e67\u2013e77 (2022).","journal-title":"lancet Healthy Longev."},{"key":"70797_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2024.111995","volume":"222","author":"J Tavenier","year":"2024","unstructured":"Tavenier, J. et al. Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases. Mech. Ageing Dev. 222, 111995 (2024).","journal-title":"Mech. Ageing Dev."},{"key":"70797_CR20","doi-asserted-by":"publisher","first-page":"111888","DOI":"10.1016\/j.mad.2023.111888","volume":"217","author":"AN Rad","year":"2024","unstructured":"Rad, A. N. & Grillari, J. Current senolytics: Mode of action, efficacy and limitations, and their future. Mech. Ageing Dev. 217, 111888 (2024).","journal-title":"Mech. Ageing Dev."},{"key":"70797_CR21","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1007\/s11357-021-00457-4","volume":"43","author":"JB Chae","year":"2021","unstructured":"Chae, J. B. et al. Targeting senescent retinal pigment epithelial cells facilitates retinal regeneration in mouse models of age-related macular degeneration. Geroscience 43, 2809\u20132833 (2021).","journal-title":"Geroscience"},{"key":"70797_CR22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.14348\/molcells.2023.2188","volume":"46","author":"W Ryu","year":"2023","unstructured":"Ryu, W., Park, C. W., Kim, J., Lee, H. & Chung, H. The Bcl-2\/Bcl-xL Inhibitor ABT-263 attenuates retinal degeneration by selectively inducing apoptosis in senescent retinal pigment epithelial cells. Mol. Cells 46, 420\u2013429 (2023).","journal-title":"Mol. Cells"},{"key":"70797_CR23","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.18632\/aging.204187","volume":"14","author":"H Chung","year":"2022","unstructured":"Chung, H. & Kim, C. Nutlin-3a for age-related macular degeneration. Aging 14, 5614\u20135616 (2022).","journal-title":"Aging"},{"key":"70797_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101\u2013124 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70797_CR25","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1039\/D2BM00010E","volume":"10","author":"JY Oh","year":"2022","unstructured":"Oh, J. Y., Yang, G., Choi, E. & Ryu, J.-H. Mesoporous silica nanoparticle-supported nanocarriers with enhanced drug loading, encapsulation stability, and targeting efficiency. Biomater. Sci. 10, 1448\u20131455 (2022).","journal-title":"Biomater. Sci."},{"key":"70797_CR26","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.2147\/JMDH.S313968","volume":"14","author":"A Tewabe","year":"2021","unstructured":"Tewabe, A., Abate, A., Tamrie, M., Seyfu, A. & Abdela Siraj, E. Targeted drug delivery - from magic bullet to nanomedicine: principles, challenges, and future perspectives. J. Multidiscip. Healthc. 14, 1711\u20131724 (2021).","journal-title":"J. Multidiscip. Healthc."},{"key":"70797_CR27","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.2147\/IJN.S469110","volume":"19","author":"Y Shi","year":"2024","unstructured":"Shi, Y. et al. Advances in nanotherapy for targeting senescent cells. Int. J. Nanomed. 19, 8797\u20138813 (2024).","journal-title":"Int. J. Nanomed."},{"key":"70797_CR28","doi-asserted-by":"publisher","first-page":"113737","DOI":"10.1016\/j.biopha.2022.113737","volume":"155","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q., Li, S., Chen, F., Zeng, R. & Tong, R. Targeted delivery strategy: A beneficial partner for emerging senotherapy. Biomed. Pharmacother. 155, 113737 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"70797_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","volume":"47","author":"LJ Hickson","year":"2019","unstructured":"Hickson, L. J. et al. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine 47, 446\u2013456 (2019).","journal-title":"EBioMedicine"},{"key":"70797_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41591-024-02802-4","volume":"30","author":"S Crespo-Garcia","year":"2024","unstructured":"Crespo-Garcia, S. et al. Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results. Nat. Med. 30, 443\u2013454 (2024).","journal-title":"Nat. Med."},{"key":"70797_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tim.2010.06.010","volume":"18","author":"DT Evans","year":"2010","unstructured":"Evans, D. T., Serra-Moreno, R., Singh, R. K. & Guatelli, J. C. BST-2\/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol. 18, 388\u2013396 (2010).","journal-title":"Trends Microbiol."},{"key":"70797_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj7398","volume":"7","author":"B Olety","year":"2021","unstructured":"Olety, B., Peters, P., Wu, Y., Usami, Y. & G\u00f6ttlinger, H. HIV-1 propagation is highly dependent on basal levels of the restriction factor BST2. Sci. Adv. 7, eabj7398 (2021).","journal-title":"Sci. Adv."},{"key":"70797_CR33","doi-asserted-by":"crossref","unstructured":"Kim, G. et al. YAP activation reverses aging-related visual dysfunction caused by impaired cell\u2012matrix adhesion. bioRxiv, 2026.2001.2007.697636 (2026).","DOI":"10.64898\/2026.01.07.697636"},{"key":"70797_CR34","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s42003-022-03676-3","volume":"5","author":"H Lee","year":"2022","unstructured":"Lee, H. et al. Single-cell transcriptome of the mouse retinal pigment epithelium in response to a low-dose of doxorubicin. Commun. Biol. 5, 722 (2022).","journal-title":"Commun. Biol."},{"key":"70797_CR35","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jcis.2023.06.173","volume":"649","author":"G Yang","year":"2023","unstructured":"Yang, G. et al. Surface protein-retractive and redox-degradable mesoporous organosilica nanoparticles for enhanced cancer therapy. J. Colloid Interface Sci. 649, 1014\u20131022 (2023).","journal-title":"J. Colloid Interface Sci."},{"key":"70797_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06979-4","volume":"9","author":"JY Oh","year":"2018","unstructured":"Oh, J. Y. et al. Cloaking nanoparticles with protein corona shield for targeted drug delivery. Nat. Commun. 9, 4548 (2018).","journal-title":"Nat. Commun."},{"key":"70797_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.144357","volume":"470","author":"JY Oh","year":"2023","unstructured":"Oh, J. Y. et al. Antibody plug-and-playable nanoparticles as a facile and versatile platform for targeted drug delivery. Chem. Eng. J. 470, 144357 (2023).","journal-title":"Chem. Eng. J."},{"key":"70797_CR38","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1002\/cbic.202100412","volume":"22","author":"B Jana","year":"2021","unstructured":"Jana, B. et al. Mitochondrial membrane disrupting molecules for selective killing of senescent cells. ChemBioChem 22, 3391\u20133397 (2021).","journal-title":"ChemBioChem"},{"key":"70797_CR39","doi-asserted-by":"publisher","first-page":"21991","DOI":"10.1021\/jacs.3c06898","volume":"145","author":"S Kim","year":"2023","unstructured":"Kim, S. et al. Supramolecular senolytics via intracellular oligomerization of peptides in response to elevated reactive oxygen species levels in aging cells. J. Am. Chem. Soc. 145, 21991\u201322008 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"70797_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.it.2025.01.008","volume":"46","author":"M Shojaei","year":"2025","unstructured":"Shojaei, M. & McLean, A. S. Interferon-stimulated gene IFI27 as a multifaceted candidate target in precision medicine. Trends Immunol. 46, 219\u2013228 (2025).","journal-title":"Trends Immunol."},{"key":"70797_CR41","doi-asserted-by":"publisher","first-page":"111536","DOI":"10.1016\/j.msec.2020.111536","volume":"118","author":"S Mollazadeh","year":"2021","unstructured":"Mollazadeh, S., Mackiewicz, M. & Yazdimamaghani, M. Recent advances in the redox-responsive drug delivery nanoplatforms: A chemical structure and physical property perspective. Mater. Sci. Eng. C., Mater. Biol. Appl. 118, 111536 (2021).","journal-title":"Mater. Sci. Eng. C., Mater. Biol. Appl."},{"key":"70797_CR42","first-page":"1784","volume":"14","author":"H Al-Hussaini","year":"2008","unstructured":"Al-Hussaini, H., Kam, J. H., Vugler, A., Semo, M. & Jeffery, G. Mature retinal pigment epithelium cells are retained in the cell cycle and proliferate in vivo. Mol. Vis. 14, 1784\u20131791 (2008).","journal-title":"Mol. Vis."},{"key":"70797_CR43","first-page":"570","volume":"16","author":"PL von Leithner","year":"2010","unstructured":"von Leithner, P. L., Ciurtin, C. & Jeffery, G. Microscopic mammalian retinal pigment epithelium lesions induce widespread proliferation with differences in magnitude between center and periphery. Mol. Vis. 16, 570\u2013581 (2010).","journal-title":"Mol. Vis."},{"key":"70797_CR44","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamaophthalmol.2024.1269","volume":"142","author":"DJ Fu","year":"2024","unstructured":"Fu, D. J. et al. Pegcetacoplan treatment and consensus features of geographic atrophy over 24 months. JAMA Ophthalmol. 142, 548\u2013558 (2024).","journal-title":"JAMA Ophthalmol."},{"key":"70797_CR45","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","volume":"37","author":"SS Patel","year":"2023","unstructured":"Patel, S. S. et al. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye 37, 3551\u20133557 (2023).","journal-title":"Eye"},{"key":"70797_CR46","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","volume":"68","author":"C Tse","year":"2008","unstructured":"Tse, C. et al. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res 68, 3421\u20133428 (2008).","journal-title":"Cancer Res"},{"key":"70797_CR47","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.2217\/fon-2021-0140","volume":"17","author":"M Puglisi","year":"2021","unstructured":"Puglisi, M. et al. A phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors. Future Oncol. 17, 2747\u20132758 (2021).","journal-title":"Future Oncol."},{"key":"70797_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107016","volume":"26","author":"M Kitao","year":"2023","unstructured":"Kitao, M. et al. Identification of BST2 as a conjunctival epithelial stem\/progenitor cell marker. iScience 26, 107016 (2023).","journal-title":"iScience"},{"key":"70797_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0784-9","volume":"566","author":"M De Cecco","year":"2019","unstructured":"De Cecco, M. et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature 566, 73\u201378 (2019).","journal-title":"Nature"},{"key":"70797_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108918","volume":"215","author":"PG Sreekumar","year":"2022","unstructured":"Sreekumar, P. G., Reddy, S. T., Hinton, D. R. & Kannan, R. Mechanisms of RPE senescence and potential role of \u03b1B crystallin peptide as a senolytic agent in experimental AMD. Exp. Eye Res. 215, 108918 (2022).","journal-title":"Exp. Eye Res"},{"key":"70797_CR51","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.celrep.2019.12.082","volume":"30","author":"LD Orozco","year":"2020","unstructured":"Orozco, L. D. et al. Integration of eQTL and a single-cell atlas in the human eye identifies causal genes for age-related macular degeneration. Cell Rep. 30, 1246\u20131259.e1246 (2020).","journal-title":"Cell Rep."},{"key":"70797_CR52","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1093\/hmg\/ddad007","volume":"32","author":"J Collin","year":"2023","unstructured":"Collin, J. et al. Single-cell RNA sequencing reveals transcriptional changes of human choroidal and retinal pigment epithelium cells during fetal development, in healthy adult and intermediate age-related macular degeneration. Hum. Mol. Genet. 32, 1698\u20131710 (2023).","journal-title":"Hum. Mol. Genet."},{"key":"70797_CR53","doi-asserted-by":"publisher","first-page":"e3000365","DOI":"10.1371\/journal.pbio.3000365","volume":"17","author":"Y Hu","year":"2019","unstructured":"Hu, Y. et al. Dissecting the transcriptome landscape of the human fetal neural retina and retinal pigment epithelium by single-cell RNA-seq analysis. PLoS Biol. 17, e3000365 (2019).","journal-title":"PLoS Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70797-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T15:08:13Z","timestamp":1778425693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70797-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70797"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70797-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4135"}}